Bone Marrow Mesenchymal Stem Cells Inhibit Lipopolysaccharide-Induced Inflammatory Reactions in Macrophages and Endothelial Cells

Background. Systemic inflammatory response syndrome (SIRS) accompanied by trauma can lead to multiple organ dysfunction syndrome (MODS) and even death. Early inhibition of the inflammation is necessary for damage control. Bone marrow mesenchymal stem cells (BMSCs), as a novel therapy modality, have...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Dequan, Wang, Cong, Chi, Chuang, Wang, Yuanyuan, Zhao, Jing, Fang, Jun, Pan, Jingye
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4746395/
https://www.ncbi.nlm.nih.gov/pubmed/27057093
http://dx.doi.org/10.1155/2016/2631439

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4746395/
https://www.ncbi.nlm.nih.gov/pubmed/27057093
http://dx.doi.org/10.1155/2016/2631439

Ejemplares similares